Meningococcal polysaccharide vaccine Pregnancy and Breastfeeding Warnings

Brand names: Menomune A/C/Y/W-135

Meningococcal polysaccharide vaccine Pregnancy Warnings

Use is recommended only if clearly needed and the benefit outweighs the risk.

AU TGA pregnancy category: B2
US FDA pregnancy category: C

Animal studies do not indicate direct or indirect harm to the fetus. There are no controlled data in human pregnancy. There is no convincing evidence of fetal risk from immunization of pregnant women using an inactivated bacterial vaccine.

AU TGA pregnancy category B2: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals are inadequate or may be lacking, but available data show no evidence of an increased occurrence of fetal damage.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Meningococcal polysaccharide vaccine Breastfeeding Warnings

Caution is recommended. Use only if clearly needed and the benefit outweighs the risk.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

See references

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer